NCT03673527View on ClinicalTrials.gov

Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 22, 2018

Primary Completion Date

February 4, 2019

Study Completion Date

February 11, 2019

Conditions
Healthy
Interventions
DRUG

topical formulation of tacrolimus

Topical application of tacrolimus twice daily for 14 days (one dose on Day 14).

Trial Locations (1)

89231

Investigational site, Neu-Ulm

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY

NCT03673527 - Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin | Biotech Hunter | Biotech Hunter